Osimertinib in untreated epidermal growth factor receptor (
EGFR
)-mutated advanced non-small cell lung cancer
Transl Lung Cancer Res
.
2018 Apr;7(Suppl 2):S165-S170.
doi: 10.21037/tlcr.2018.03.19.
Authors
Vanesa Gregorc
1
,
Chiara Lazzari
1
,
Niki Karachaliou
2
,
Rafael Rosell
3
4
,
Mariacarmela Santarpia
5
Affiliations
1
Department of Oncology, Division of Experimental Medicine, IRCCS San Raffaele, Milan, Italy.
2
Institute of Oncology Rosell (IOR), University Hospital Sagrat Cor, Barcelona, Spain.
3
Cancer Biology and Precision Medicine Program, Germans Trias i Pujol Research Institute, Badalona, Spain.
4
Catalan Institute of Oncology, Germans Trias i Pujol University Hospital, Badalona, Spain.
5
Medical Oncology Unit, Department of Human Pathology of Adult and Evolutive Age "G. Barresi", University of Messina, Messina, Italy.
PMID:
29782558
PMCID:
PMC5943214
DOI:
10.21037/tlcr.2018.03.19
No abstract available
Publication types
Editorial
Comment